FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084451812> ?p ?o ?g. }

• W2084451812 endingPage "1047" @default.
• W2084451812 startingPage "1045" @default.
• W2084451812 abstract "NEW DRUGS don't just 'happen' by a process of spontaneous generation: rather, their emergence into the clinical spotlight is acheived in a tentative series of evolutionary nudges, with the 'fitness' of the candidate molecule moulded by the selection forces imposed by laboratory and clinical environments. As in most human endeavours inquisitiveness and awareness are the catalysts to innovation, but luck plays a major role, especially when contrasting but complementary research strands converge at the right time in the right place. So it was with the discovery of temozolomide which is a story of a symbiotic relationship between two cultures; on the one hand the laboratory sciences of chemistry and pharmacology and on the other the clinical sciences which impose the ultimate test of efficacy does the drug actually work in patients, or not. The ancestor molecules of the bicyclic nucleus of temozolomide were originally synthesised in the early 1960s at Nottingham University and their structural similarity to temozolomide itself will be obvious (Fig. 1). The pyrazolo-l,2,4-triazines proved to have modest inhibitory properties against the mouse sarcoma 180 and a methylcholanthrene-induced rat sarcoma [1 ], but at the time there was no mechanism for evaluating the clinical potential of these leads. A series of imidazo-l,2,4triazinones and 1,2,3-benzotriazinones prepared at Aston University in the 1970s were completely lacking in antitumour activity against the available tumour models of the day, the L1210 and P388 leukaemias of the NCI. Despite these disappointments, the experience gained in exploring the chemical properties of these reactive close relatives of temozolomide was the essential foundation stone in the whole programme [2]. In 1978 the pharmaceutical company May & Baker agreed to fund a programme of inquisitive chemistry extending the foregoing studies at Aston and a pharmacy research student Robert Stone was recruited and given the simple instruction by his academic and industrial supervisors: Make some" @default.
• W2084451812 created "2016-06-24" @default.
• W2084451812 creator A5045382412 @default.
• W2084451812 creator A5062389516 @default.
• W2084451812 date "1993-01-01" @default.
• W2084451812 modified "2023-10-18" @default.
• W2084451812 title "From triazines and triazenes to temozolomide" @default.
• W2084451812 cites W1964752349 @default.
• W2084451812 cites W2000792342 @default.
• W2084451812 cites W2037192776 @default.
• W2084451812 cites W2041786299 @default.
• W2084451812 cites W2052064353 @default.
• W2084451812 cites W2066686182 @default.
• W2084451812 cites W2074139195 @default.
• W2084451812 cites W2075034527 @default.
• W2084451812 cites W2079786467 @default.
• W2084451812 cites W2109549713 @default.
• W2084451812 cites W4240236902 @default.
• W2084451812 cites W2128314173 @default.
• W2084451812 doi "https://doi.org/10.1016/s0959-8049(05)80221-7" @default.
• W2084451812 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8499135" @default.
• W2084451812 hasPublicationYear "1993" @default.
• W2084451812 type Work @default.
• W2084451812 sameAs 2084451812 @default.
• W2084451812 citedByCount "62" @default.
• W2084451812 countsByYear W20844518122012 @default.
• W2084451812 countsByYear W20844518122013 @default.
• W2084451812 countsByYear W20844518122014 @default.
• W2084451812 countsByYear W20844518122015 @default.
• W2084451812 countsByYear W20844518122016 @default.
• W2084451812 countsByYear W20844518122017 @default.
• W2084451812 countsByYear W20844518122018 @default.
• W2084451812 countsByYear W20844518122019 @default.
• W2084451812 countsByYear W20844518122020 @default.
• W2084451812 countsByYear W20844518122021 @default.
• W2084451812 countsByYear W20844518122022 @default.
• W2084451812 countsByYear W20844518122023 @default.
• W2084451812 crossrefType "journal-article" @default.
• W2084451812 hasAuthorship W2084451812A5045382412 @default.
• W2084451812 hasAuthorship W2084451812A5062389516 @default.
• W2084451812 hasConcept C2776194525 @default.
• W2084451812 hasConcept C2777389519 @default.
• W2084451812 hasConcept C502942594 @default.
• W2084451812 hasConcept C71924100 @default.
• W2084451812 hasConceptScore W2084451812C2776194525 @default.
• W2084451812 hasConceptScore W2084451812C2777389519 @default.
• W2084451812 hasConceptScore W2084451812C502942594 @default.
• W2084451812 hasConceptScore W2084451812C71924100 @default.
• W2084451812 hasIssue "7" @default.
• W2084451812 hasLocation W20844518121 @default.
• W2084451812 hasLocation W20844518122 @default.
• W2084451812 hasOpenAccess W2084451812 @default.
• W2084451812 hasPrimaryLocation W20844518121 @default.
• W2084451812 hasRelatedWork W1506200166 @default.
• W2084451812 hasRelatedWork W1995515455 @default.
• W2084451812 hasRelatedWork W2048182022 @default.
• W2084451812 hasRelatedWork W2080531066 @default.
• W2084451812 hasRelatedWork W2604872355 @default.
• W2084451812 hasRelatedWork W2748952813 @default.
• W2084451812 hasRelatedWork W2899084033 @default.
• W2084451812 hasRelatedWork W3031052312 @default.
• W2084451812 hasRelatedWork W3032375762 @default.
• W2084451812 hasRelatedWork W3108674512 @default.
• W2084451812 hasVolume "29" @default.
• W2084451812 isParatext "false" @default.
• W2084451812 isRetracted "false" @default.
• W2084451812 magId "2084451812" @default.
• W2084451812 workType "article" @default.